NCT01643603 2020-12-17Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesBarbara Ann Karmanos Cancer InstitutePhase 1 Terminated5 enrolled
NCT00569179 2015-08-31A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid MalignanciesIndiana UniversityPhase 1 Terminated1 enrolled
NCT00111683 2015-08-25MK0457 in Patients With Leukemia (0457-003)Merck Sharp & Dohme LLCPhase 1 Completed28 enrolled
NCT00464113 2015-08-21Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaExelixisPhase 1 Terminated49 enrolled